Ezra M Friedberg insider trades

Open-market stock purchases and sales by Ezra M Friedberg, Director at Pelthos Therapeutics Inc, from SEC Form 4 filings since Sep 13, 2016.

Recent trades

DateStockTradeValue
Jul 2, 2026PTHS Pelthos Therapeutics IncSold$13.9K
Jul 2, 2026PTHS Pelthos Therapeutics IncSold$656
Jun 15, 2026PTHS Pelthos Therapeutics IncSold$6.1K
Jun 15, 2026PTHS Pelthos Therapeutics IncSold$1.6K
May 14, 2026PTHS Pelthos Therapeutics IncSold (not open market)$3.9K
Apr 2, 2026PTHS Pelthos Therapeutics IncSold$6K
Apr 2, 2026PTHS Pelthos Therapeutics IncSold$5.7K
Nov 25, 2025PTHS Pelthos Therapeutics IncSold$168K
Nov 25, 2025PTHS Pelthos Therapeutics IncSold$29
Nov 25, 2025PTHS Pelthos Therapeutics IncSold$56K

Companies traded

  • PTHS Pelthos Therapeutics Inc: 1 buy, 9 sales, last Jul 2, 2026
  • CHRO Chromocell Therapeutics Corp: 1 buy, last Nov 13, 2024
  • KBIO Kalobios Pharmaceuticals Inc: other filings, last Sep 13, 2016

Get free alerts when Ezra M Friedberg files a new trade →